Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer

Purpose: A growing number of treatment options and active compounds in treatments have led to better outcomes for patients with advanced or recurrent epithelial ovarian cancer. We examined the association between progression-free survival (PFS), post-progression survival (PPS) and overall survival (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cancer
Autori principali: Shimokawa, Mototsugu, Kogawa, Takahiro, Shimada, Takako, Saito, Toshiaki, Kumagai, Hozumi, Ohki, Masafumi, Kaku, Tsunehisa
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ivyspring International Publisher 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868151/
https://ncbi.nlm.nih.gov/pubmed/29581765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17664
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi